These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 16245219)
1. A new marker for lipid peroxidation: serum paraoxonase activity in non-alcoholic steatohepatitis. Başkol M; Başkol G; Deniz K; Ozbakir O; Yücesoy M Turk J Gastroenterol; 2005 Sep; 16(3):119-23. PubMed ID: 16245219 [TBL] [Abstract][Full Text] [Related]
2. Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin. Samy W; Hassanian MA Arab J Gastroenterol; 2011 Jun; 12(2):80-5. PubMed ID: 21684478 [TBL] [Abstract][Full Text] [Related]
3. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients. Yavuz DG; Yüksel M; Deyneli O; Ozen Y; Aydin H; Akalin S Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886 [TBL] [Abstract][Full Text] [Related]
4. Serum paraoxonase 1 activity and malondialdehyde levels in patients with ulcerative colitis. Baskol G; Baskol M; Yurci A; Ozbakir O; Yucesoy M Cell Biochem Funct; 2006; 24(3):283-6. PubMed ID: 15830398 [TBL] [Abstract][Full Text] [Related]
5. Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Baskol G; Demir H; Baskol M; Kilic E; Ates F; Kocer D; Muhtaroglu S Clin Biochem; 2005 Oct; 38(10):951-5. PubMed ID: 16055108 [TBL] [Abstract][Full Text] [Related]
6. Orlistat increases serum paraoxonase activity in obese patients. Audikovszky M; Pados G; Seres I; Harangi M; Fülöp P; Katona E; Illyés L; Winkler G; Katona EM; Paragh G Nutr Metab Cardiovasc Dis; 2007 May; 17(4):268-73. PubMed ID: 17134960 [TBL] [Abstract][Full Text] [Related]
7. Marked elevation of serum mitochondrion-derived markers in mild models of non-alcoholic steatohepatitis in rats. Murayama H; Ikemoto M; Nagata A J Gastroenterol Hepatol; 2009 Feb; 24(2):270-7. PubMed ID: 18823438 [TBL] [Abstract][Full Text] [Related]
8. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis. Bahcecioglu IH; Yalniz M; Ataseven H; Ilhan N; Ozercan IH; Seckin D; Sahin K Hepatogastroenterology; 2005; 52(65):1549-53. PubMed ID: 16201116 [TBL] [Abstract][Full Text] [Related]
9. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation. Serhatlioglu S; Gursu MF; Gulcu F; Canatan H; Godekmerdan A Cell Biochem Funct; 2003 Dec; 21(4):371-5. PubMed ID: 14624476 [TBL] [Abstract][Full Text] [Related]
10. Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis. Koruk M; Tayşi S; Savaş MC; Yilmaz O; Akçay F; Karakök M Turk J Gastroenterol; 2003 Mar; 14(1):12-7. PubMed ID: 14593532 [TBL] [Abstract][Full Text] [Related]
11. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease. Gulsen M; Yesilova Z; Bagci S; Uygun A; Ozcan A; Ercin CN; Erdil A; Sanisoglu SY; Cakir E; Ates Y; Erbil MK; Karaeren N; Dagalp K J Gastroenterol Hepatol; 2005 Sep; 20(9):1448-55. PubMed ID: 16105135 [TBL] [Abstract][Full Text] [Related]
12. Levels of paraoxonase, an index of antioxidant defense, in patients with active sarcoidosis. Uzun H; Yanardag H; Gelisgen R; Genc H; Uygun S; Vehid S; Karter Y; Demirci S Curr Med Res Opin; 2008 Jun; 24(6):1651-7. PubMed ID: 18474147 [TBL] [Abstract][Full Text] [Related]
13. Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis. Baskol G; Baskol M; Kocer D Clin Biochem; 2007 Jul; 40(11):776-80. PubMed ID: 17477913 [TBL] [Abstract][Full Text] [Related]
14. Serum ubiquitin levels in patients with nonalcoholic steatohepatitis. Savas MC; Koruk M; Pirim I; Yilmaz O; Karakok M; Taysi S; Yilmaz A Hepatogastroenterology; 2003; 50(51):738-41. PubMed ID: 12828075 [TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver. Loguercio C; De Simone T; D'Auria MV; de Sio I; Federico A; Tuccillo C; Abbatecola AM; Del Vecchio Blanco C; Dig Liver Dis; 2004 Jun; 36(6):398-405. PubMed ID: 15248380 [TBL] [Abstract][Full Text] [Related]
16. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis. Ito S; Yukawa T; Uetake S; Yamauchi M Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172 [TBL] [Abstract][Full Text] [Related]
17. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population. Elkiran ET; Mar N; Aygen B; Gursu F; Karaoglu A; Koca S BMC Cancer; 2007 Mar; 7():48. PubMed ID: 17362500 [TBL] [Abstract][Full Text] [Related]
18. Serum paraoxonase activity in uremic predialysis and hemodialysis patients. Dirican M; Akca R; Sarandol E; Dilek K J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056 [TBL] [Abstract][Full Text] [Related]
19. Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis. Aslan M; Horoz M; Nazligul Y; Bolukbas C; Bolukbas FF; Selek S; Aksoy N; Erel O Int J Clin Pract; 2008 Jul; 62(7):1050-5. PubMed ID: 17887991 [TBL] [Abstract][Full Text] [Related]
20. Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity. Keskin M; Dolar E; Dirican M; Kiyici M; Yilmaz Y; Gurel S; Nak SG; Erdinc S; Gulten M Intern Med J; 2009 Apr; 39(4):243-8. PubMed ID: 19402863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]